Clinical Trial Update: Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Elvucitabine/Efavirenz/Tenofovir to Lamivudine/Efavirenz/Tenofovir in treatment-naive HIV-1 patients; study completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Elvucitabine/EFV/Tenofovir
• Lamivudine/EFV/Tenofovir

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2016-03-22